CD28 has been described as the primary target for PD-1-mediated T-cell suppression66 and CD28+ CD8 T cells were the predominant subset proliferating under PD-1 blockade in patients with lung cancer.67 The gene discussed is CD8A; the disease is lung carcinoma.